Shyr-yi Y. Lin
250 Wusing Street
Taipei, TNQ 11031, Taiwan
Taipei, TNQ 11031, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Tumor Antigen-Tethered Spiked Virus-Like- Poly(Lactic-Co-Glycolic Acid)-Nanoparticle Vaccine Enhances Antitumor Ability Through Th9 Promotion in Mice.
Journal: International journal of nanomedicine
Published: May 04, 2024
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer.
Journal: Pharmaceutics
Published: November 11, 2022
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer.
Journal: International journal of nanomedicine
Published: August 30, 2022
A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells.
Journal: Journal of biomedical science
Published: May 25, 2022
Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment.
Journal: Pharmaceutics
Published: April 29, 2022
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor.
Journal: Biomaterials science
Published: November 26, 2021
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 04, 2021
Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas.
Journal: International journal of nanomedicine
Published: July 28, 2021
Last Updated: 09/26/2026